Voorbeelden van het gebruik van Randomised double-blind in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Randomised, double-blind treatment regimen week 18 to 34.
To complete a multicentre, randomised, double-blind, placebo-controlled.
A randomised, double-blind, placebo-controlled study was conducted in 405 patients with pulmonary arterial hypertension.
was randomised, double-blind, and placebo controlled.
A randomised, double-blind, placebo-controlled study was performed in 272 patients aged 7-17 years with generalised anxiety disorder.
The efficacy of etanercept was assessed in a randomised, double-blind, placebo-controlled study.
Monotherapy; randomised double-blind placebo-controlled parallel-group trial for 120 weeks.
The efficacy of infliximab was assessed in two multicentre, randomised, double-blind, pivotal clinical studies.
The Phase 3 study was a randomised, double-blind, placebo-controlled, parallel group study that included 789 patients.
for smoking cessation in subjects with mild-moderate COPD was demonstrated in a randomised double-blind placebo-controlled clinical trial.
Study 108 was a randomised, double-blind, parallel-group, placebo-controlled, Phase 3 study conducted in treatment-naïve patients.
Once-per-cycle dosing of lipegfilgrastim was investigated in two pivotal randomised, double-blind clinical studies in patients undergoing myelosuppressive chemotherapy.
In a randomised double-blind clinical trial, 839 patients were treated with
were studied in controlled randomised double-blind phase III clinical studies, the RECORD-programme.
In at least four randomised double-blind placebo-controlled clinical studies saffron was found to be effective in the treatment of depression.
The safety and efficacy of Humira were also studied in adult patients with moderate to severe chronic plaque psoriasis with concomitant hand and/or foot psoriasis who were candidates for systemic therapy in a randomised double-blind study Psoriasis Study III.
Study 312-0116 was a randomised, double-blind, placebo-controlled study in which 110 subjects with previously treated CLL received idelalisib+ rituximab.
The effect of pneumococcal conjugate vaccination on nasopharyngeal carriage was studied in a randomised double-blind study in which infants received either Prevenar 13
In a randomised double-blind clinical trial, 737 patients were
Efficacy against cholera was assessed in three randomised double-blind placebo-controlled clinical trials conducted in Bangladesh(endemic region)
A randomised, double-blind, parallel-group non-inferiority study compared the relative efficacy of two different daily maintenance doses of leflunomide,
The effects of AVONEX in the treatment of MS were also demonstrated in a randomised double-blind study performed with 383 patients(AVONEX n=193,
In two randomised, double-blind studies with a total of 1,132 patients receiving moderately emetogenic chemotherapy that included cisplatin≤50 mg/m2, carboplatin, cyclophosphamide.
The clinical efficacy and safety of Lyxumia were evaluated in nine randomised double-blind, placebo-controlled clinical studies including 4,508 patients with type 2 diabetes 2,869 patients randomised to lixisenatide, 47.5% men and 52.5% women, and 517 were≥65 years of age.
In a randomised, double-blind, multi-centre trial in patients with functional carcinoid tumours,
In a multicentre, randomised, double-blind active control clinical trial of 635 patients set to receive moderately emetogenic cancer chemotherapy.
Study D9901 was a randomised, double-blind, controlled, multicentre trial in patients with metastatic castrate resistant prostate cancer and no cancer-related pain.
This was a phase III randomised double-blind trial conducted to evaluate the efficacy
Five randomised double-blind controlled studies have been conducted including scheduled upper gastrointestinal endoscopy in approximately 4500 patients free from initial ulceration celecoxib doses from 50 mg-400 mg BID.
A phase II, randomised double-blind study of two dose levels(200 mg